"Metronomic oral vinorelbine" trang 1 - tải miễn phí từ tailieunhanh
Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Results of a phase II trial (MOVE trial)

Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: Results of a phase II trial (MOVE trial)
6    27    1
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: Final results of the exploratory phase 2 Victor-5 study

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: Final results of the exploratory phase 2 Victor-5 study
10    1    1
Đánh giá kết quả điều trị ung thư phổi không tế bào nhỏ giai đoạn IV bằng Navelbin metronomic tại Bệnh viện Đại học Y Hà Nội

Đánh giá kết quả điều trị ung thư phổi không tế bào nhỏ giai đoạn IV bằng Navelbin metronomic tại Bệnh viện Đại học Y Hà Nội
5    42    1
Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma

Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
12    61    0
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial

Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: A dose-finding phase 1 trial
7    49    1
SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial

SAKK 24/09: Safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial
8    54    1
Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas
10    79    1
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery - a case report

From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery - a case report
6    63    1
Head and neck cancer: Metronomic chemotherapy

Head and neck cancer: Metronomic chemotherapy
5    78    1
Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: A hellenic cooperative oncology group clinical translational study

Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: A hellenic cooperative oncology group clinical translational study
12    63    1
Kết quả phân tích dưới nhóm hóa trị Vinorelbin Metronomic ung thư phổi không tế bào nhỏ giai đoạn tiến xa

Kết quả phân tích dưới nhóm hóa trị Vinorelbin Metronomic ung thư phổi không tế bào nhỏ giai đoạn tiến xa
3    36    1
Metronomic cyclophosphamide activation of anti-tumor immunity: Tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators

Metronomic cyclophosphamide activation of anti-tumor immunity: Tumor model, mouse host, and drug schedule dependence of gene responses and their upstream regulators
17    51    1
Kết quả phân tích dưới nhóm hóa trị Vinorelbin Metronomic nghiên cứu bào chế viên nang từ bài thuốc bát vị hoàn

Kết quả phân tích dưới nhóm hóa trị Vinorelbin Metronomic nghiên cứu bào chế viên nang từ bài thuốc bát vị hoàn
4    50    1
Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital

Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital
6    53    1
PRIMMO study protocol: A phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

PRIMMO study protocol: A phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer
10    68    0
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol
8    51    1
Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts

Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts
21    47    1
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study
10    37    1
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer

Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
10    2    1